Guardant Health, Inc. GH
175.51 USD +4.78 (+2.80%)
Nov 3, 2026, 3:22 PM EST
167.31 Day range 178.38
78.60 52-week range 187.22
- YTD
- +71.83%
- 1 year
- +77.43%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 202.24 +15.2% upside
Now 175.51
- Target (low)
- 105.00
- Target (mean)
- 202.24
- Target (high)
- 240.00
Ratings (0m) 26 25 buy · 0 hold · 1 sell
- Strong buy4
- Buy21
- Hold0
- Sell0
- Strong sell1
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31444 | -0.39 – -0.22 | -0.39 | +19.4% | 350.64M | +32.2% | 17 |
| Next quarter | -0.27901 | -0.57011 – -0.17 | -0.50 | +44.2% | 369.15M | +31.2% | 17 |
| Current year | -1.45 | -1.81 – -1.18 | -1.82 | +20.5% | 1.36B | +38.4% | 21 |
| Next year | -0.37917 | -1.43 – 0.7236 | -1.45 | +73.8% | 1.84B | +35.2% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 23, 2026 | Roth Capital | Initiated | — | Buy |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Sep 8, 2026 | Rothschild & Co | Initiated | — | Buy |
| Sep 2, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 3, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 31, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 8, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 6, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 2, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 1, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 11, 2026 | RBC Capital | Initiated | — | Outperform |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |